Invention Grant
- Patent Title: 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
-
Application No.: US16179709Application Date: 2018-11-02
-
Publication No.: US10561662B2Publication Date: 2020-02-18
- Inventor: Stephen Hitchcock , Betty Lam , Holger Monenschein , Holly Reichard
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agent Matthew J. Russo; David M. Stemerick
- Main IPC: C07D253/08
- IPC: C07D253/08 ; A61K31/53 ; A61P25/18
Abstract:
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
Public/Granted literature
- US20190070187A1 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE MODULATORS OF GPR139 Public/Granted day:2019-03-07
Information query
